Free Post Earnings Research Report: Teladoc’s Revenues Soared 109%

Stock Monitor: Quality Systems Post Earnings Reporting

LONDON, UK / ACCESSWIRE / May 30, 2018 / If you want access to our free earnings report on Teladoc, Inc. (NYSE: TDOC), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=TDOC. The Company reported its first quarter fiscal 2018 operating and financial results on May 01, 2018. The telehealth services provider outperformed top- and bottom-line expectations. Additionally, the Company provided guidance for the upcoming quarter and fiscal year. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Quality Systems, Inc. (NASDAQ: QSII), which also belongs to the Technology sector as the Company Teladoc. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=QSII

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Teladoc most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=TDOC

Earnings Highlights and Summary

For the first quarter of the fiscal year 2018 , Teladoc's total revenues were $89.6 million, up 109% compared to $42.9 million in Q1 2017. The Company's revenue numbers beat analysts' estimates by $2.84 million.

During Q1 2018, Teladoc's gross profit margin was 70.0% compared to 71.7% in Q1 2017.

For Q1 2018, Teladoc's earnings before interest, tax, depreciation, and amortization (EBITDA) were negative $10.8 million compared to negative $12.2 million in Q1 2017. The Company's adjusted EBITDA improved to a loss of $1.4 million in the reported quarter compared to a loss of $9.1 million in the prior year's same quarter.

Teladoc's net loss was $23.9 million, or $0.39 loss per diluted share, in Q1 2018 compared to a net loss of $15.7 million, or $0.30 per diluted share, in Q1 2017. The Company's earnings numbers were better than Wall Street's estimates for a loss of $0.43 per share.

Segment Results

During Q1 2018, Teladoc's Subscription Access Fees' revenues surged 109% to $71.7 million compared to $34.3 million in Q1 2017. The Company's US Subscription Access Fees' revenues were $61.0 million in the reported quarter compared to $34.3 million in Q1 2017, representing an increase of 78%.

For Q1 2018, Teladoc's International Subscription Access Fees' revenues were $10.7 million compared to none in Q1 2017. The Company's Visits' revenues were $17.9 million in the reported quarter compared to $8.6 million in Q1 2017, reflecting an increase of 109%. Teladoc's General Medical Visits' (including dermatology and behavioral health) revenues were $16.3 million in Q1 2018 compared to $8.6 million in Q1 2017. The Company's Other Specialty Visits' (principally expert medical opinions) revenues were $1.6 million in the reported quarter versus none in the prior year's comparable quarter.

Teladoc's total visits from US Paid Membership were 554,000 in Q1 2018 compared to 385,000 in Q1 2017, reflecting an increase of 44%. The Company's paid visits totaled 298,000, or 54% of total visits from US paid membership, in the reported quarter compared to 217,000 paid visits, or 56% of total visits, in the prior year's corresponding quarter.

During Q1 2018, Teladoc's total US paid membership was 20.8 million, an increase of 41% compared to Q1 2017. The Company's US paid membership was 14.8 million. The Company's organic US paid membership growth was 27% in the reported quarter. Teladoc's total US Visit Fee Only access, which was launched on January 01, 2018, was available to 9.5 million individuals.

Business Outlook

For the second quarter of the fiscal year 2018, Teladoc is forecasting revenues to be in the range of $86 million to $87 million. The Company's adjusted EBITDA is expected to be in the band of $1.5 million to $2.5 million. For Q2 2018, Teladoc's US paid membership is expected to total approximately 20.8 million to 21.0 million and visit fee only access is expected to total between of 18 million to 18.5 million individuals at June 30, 2018. The Company's total visits are projected to be between 450,000 and 500,000 for the upcoming quarter. For Q2 2018, Teladoc is projecting net loss per diluted share to be between $0.35 and $0.37.

For the full fiscal year 2018, Teladoc is projecting revenues to be in the range of $350 million to $360 million. The Company's adjusted EBITDA is anticipated to be positive in the band of $7 million to $10 million. For FY18, Teladoc's US paid membership is expected to be approximately 22 million to 24 million, while total visits are projected to be between 1.9 million to 2.0 million. The Company is anticipating net loss per share to be in the range of $1.36 and $1.41 for FY18.

Stock Performance Snapshot

May 29, 2018 - At Tuesday's closing bell, Teladoc's stock slightly advanced 0.20%, ending the trading session at $50.80.

Volume traded for the day: 976.94 thousand shares, which was above the 3-month average volume of 969.54 thousand shares.

Stock performance in the last month – up 18.14%; previous three-month period – up 36.19%; past twelve-month period – up 67.66%; and year-to-date – up 45.77%

After yesterday's close, Teladoc's market cap was at $3.16 billion.

The stock is part of the Technology sector, categorized under the Healthcare Information Services industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst. For further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors